Erik R. Dubberke

机构：Washington University in St. Louis · ORCID：0000-0003-3779-2796

发表论文 362 篇 · 总被引 18922 次 · h-index 66

代表论文

• CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection (2024 · Clinical Infectious Diseases · 被引 37)
• A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response (2024 · Clinical Infectious Diseases · 被引 35)
• PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection (2024 · Clinical Infectious Diseases · 被引 34)
• Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study (2024 · EClinicalMedicine · 被引 31)
• Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting (2024 · mBio · 被引 13)
• Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization (2024 · Cell Host & Microbe · 被引 10)